ImmunityBio, Inc.IBRXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-87.6%
5Y CAGR-71.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-87.6%/yr
vs +1.3%/yr prior
5Y CAGR
-71.4%/yr
Recent deceleration
Acceleration
-88.9pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 16.08 | -86.7% |
| 2024 | 121.07 | -97.1% |
| 2023 | 4105.07 | -51.4% |
| 2022 | 8447.89 | +233.4% |
| 2021 | 2533.77 | -70.0% |
| 2020 | 8442.61 | -75.0% |
| 2019 | 33773.25 | +321.0% |
| 2018 | 8022.39 | -74.6% |
| 2017 | 31544.39 | -26.1% |
| 2016 | 42711.99 | - |